<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04055662</url>
  </required_header>
  <id_info>
    <org_study_id>2108.2.7</org_study_id>
    <nct_id>NCT04055662</nct_id>
  </id_info>
  <brief_title>A Comparison of Post-Operative Analgesia Requirements In Recreational Cannabis Users Versus Cannabis Na√Øve Inflammatory Bowel Disease Patients</brief_title>
  <official_title>A Comparison of Post-Operative Analgesia Requirements In Recreational Cannabis Users</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mount Sinai Hospital, Canada</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mount Sinai Hospital, Canada</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cannabis is a drug that is widely used for recreational purpose. In most patients undergoing
      surgery, opioids are the most widely used mode of pain relief, during and following surgery.
      Anecdotally it has been observed that cannabis users required unexpectedly high doses of
      opioids. The purpose of this study is to compare opioid requirements between cannabis users
      and non- users after the surgery. Currently, post-operative opioid doses are determined based
      on various patient factors such as pre-operative opioid use, patient weight, age and
      sensitivity to opioids during surgery. Patients' requirements may be underestimated and
      opioid regimens need to be escalated in the first 24 hours in order to alleviate uncontrolled
      pain in cannabis users. Better understanding of the impacts of cannabis use on post-operative
      opioid requirements would help the Acute Pain Service optimize post-operative pain management
      for patients who use cannabis pre-operatively.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid consumption</measure>
    <time_frame>2 years</time_frame>
    <description>Amount of morphine equivalents on PCA</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cannabis Use, Opioid Consumption</condition>
  <arm_group>
    <arm_group_label>Cannabis users</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Cannabis naive</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Elective IBD bowel surgery under general anesthesia
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Consent to participate and signed consent form.

          2. Age: 18-65 years.

          3. Elective IBD bowel surgery under general anesthesia.

          4. PCA use.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Zeev Friedman</last_name>
    <phone>4165865270</phone>
    <email>zeev.friedman@uhn.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sinai Health System</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G1X2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zeev Friedman</last_name>
      <phone>4165865270</phone>
      <email>zeev.friedman@uhn.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 12, 2019</study_first_submitted>
  <study_first_submitted_qc>August 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2019</study_first_posted>
  <last_update_submitted>August 12, 2019</last_update_submitted>
  <last_update_submitted_qc>August 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Marijuana Abuse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

